Old Web
English
Sign In
Acemap
>
Paper
>
359: Ultrasound as a second screen after positive cell-free DNA for trisomy 21: A cost-effectiveness analysis
359: Ultrasound as a second screen after positive cell-free DNA for trisomy 21: A cost-effectiveness analysis
2020
Carmen M. Avram
Brian L Shaffer
Aaron B. Caughey
Keywords:
Cell-free fetal DNA
Cost-effectiveness analysis
Diabetes mellitus
Second screen
Medicine
Ultrasound
Obstetrics
Trisomy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]